These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8239596)

  • 1. Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen.
    Hobden JA; Hill JM; Engel LS; O'Callaghan RJ
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1856-9. PubMed ID: 8239596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis.
    Hobden JA; Engel LS; Hill JM; Callegan MC; O'Callaghan RJ
    Curr Eye Res; 1993 May; 12(5):469-73. PubMed ID: 8344070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.
    Hobden JA; O'Callaghan RJ; Hill JM; Hagenah M; Insler MS; Reidy JJ
    Curr Eye Res; 1992 Mar; 11(3):259-65. PubMed ID: 1587148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
    Engel LS; Callegan MC; Hobden JA; Reidy JJ; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nitric oxide synthase inhibition in experimental Pseudomonas keratitis in rabbits.
    Er H; Turkoz Y; Ozerol IH; Uzmez E
    Eur J Ophthalmol; 1998; 8(3):137-41. PubMed ID: 9793765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
    Reidy JJ; Hobden JA; Hill JM; Forman K; O'Callaghan RJ
    Cornea; 1991 Jan; 10(1):25-8. PubMed ID: 1902152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
    Onlen Y; Tamer C; Oksuz H; Duran N; Altug ME; Yakan S
    Microbiol Res; 2007; 162(1):62-8. PubMed ID: 16904302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits.
    O'Brien TP; Sawusch MR; Dick JD; Gottsch JD
    Arch Ophthalmol; 1988 Oct; 106(10):1444-6. PubMed ID: 3140772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis.
    Hobden JA; Reidy JJ; O'Callaghan RJ; Insler MS; Hill JM
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1940-4. PubMed ID: 2210988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD; Cohen KL
    Cornea; 1993 Nov; 12(6):517-21. PubMed ID: 8261784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin ointment versus ciprofloxacin drops for therapy of experimental Pseudomonas keratitis.
    Hobden JA; O'Callaghan RJ; Insler MS; Hill JM
    Cornea; 1993 Mar; 12(2):138-41. PubMed ID: 8500320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
    Karicherla P; Hobden JA
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
    Thibodeaux BA; Dajcs JJ; Caballero AR; Marquart ME; Girgis DO; O'Callaghan RJ
    Curr Eye Res; 2004 May; 28(5):337-42. PubMed ID: 15287370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
    Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
    Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.